L
Lineage Cell Therapeutics Inc
XBER:BT3
Lineage Cell Therapeutics Inc
XBER:BT3
Price:
1.35
EUR
Market Closed
Market Cap:
€395.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lineage Cell Therapeutics Inc
XBER:BT3
|
US |
|
C
|
China Shenhua Energy Co Ltd
SWB:IKF
|
CN |
|
Q
|
QL Resources Bhd
KLSE:QL
|
MY |
|
A
|
APA Corp (US)
BMV:APA
|
US |
|
London Stock Exchange Group PLC
LSE:LSEG
|
UK |
|
F
|
First Quantum Minerals Ltd
OTC:FQVLF
|
CA |
|
A
|
Amcor PLC
XBER:485
|
UK |
|
G
|
Gap Inc
XBER:GAP
|
US |
|
E
|
Exact Sciences Corp
F:EXK
|
US |
|
S
|
SoftBank Group Corp
SWB:SFT
|
JP |
|
G
|
GE Healthcare Technologies Inc
F:L0T
|
US |
|
A
|
Auckland International Airport Ltd
XBER:BZTA
|
NZ |
|
Kogan.com Ltd
ASX:KGN
|
AU |
|
S
|
SoftBank Corp
F:3AG1
|
JP |
|
T
|
Talisker Resources Ltd
OTC:TSKFF
|
CA |
|
Aker BP ASA
F:ARC
|
NO |
|
M
|
MTN Group Ltd
XBER:LL6
|
ZA |
DCF Valuation
is not available for Lineage Cell Therapeutics Inc
is not available for Lineage Cell Therapeutics Inc
BT3's DCF value cannot be reliably calculated.
Switch to
See Also
Other Lineage Cell Therapeutics Inc listings:
Discover More
